Uric acid as a Marker of oxidative stress in dilatation of the ascending aorta

American Journal of Hypertension

Volumn 24, Issue 2, 2011, Pages 149-154

  Esen, Ali M ^a   Akcakoyun, Mustafa ^a   Esen, Ozlem ^b   Acar, Goksel ^a   Emiroglu, Yunus ^a   Pala, Selcuk ^a   Kargin, Ramazan ^a   Karapinar, Hekim ^c   Ozcan, Omer ^d   Barutcu, Irfan ^e  

^a KOSUYOLU HEART AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Van Education and Research Hospital   (Turkey)

^d GULHANE SCHOOL OF MEDICINE   (Turkey)

^e Avicenna Hospital   (Turkey)

Author keywords

ascending aortic aneurysm; blood pressure; hypertension; oxidative stress; total antioxidant reductive capacity; uric acid

Indexed keywords

BIOCHEMICAL MARKER; URIC ACID;

ADULT; ANTIOXIDANT ACTIVITY; AORTA ANEURYSM; ARTICLE; ASCENDING AORTA; CONTROLLED STUDY; ECTASIAN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; REDUCTION; TRANSTHORACIC ECHOCARDIOGRAPHY; URIC ACID BLOOD LEVEL;

ADULT; AGED; AORTA; AORTIC ANEURYSM; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DILATATION, PATHOLOGIC; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OXIDATIVE STRESS; RISK ASSESSMENT; RISK FACTORS; TURKEY; UP-REGULATION; URIC ACID;

EID: 78751619806     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2010.219     Document Type: Article

References (36)

1. Clouse WD, Hallett JW Jr, Schaff HV, Gayari MM, Ilstrup DM, Melton LJ 3rd. Improved prognosis of thoracic aortic aneurysms: a population-based study. JAMA 1998; 280:1926-1929.
2. Dobrin PB, Baker WH, Gley WC. Elastolytic and collagenolytic studies of arteries. Implications for the mechanical properties of aneurysms. Arch Surg 1984; 119:405-409.
3. Koch AE, Haines GK, Rizzo RJ, Radosevich JA, Pope RM, Robinson PG, Pearce WH. Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol 1990; 137:1199-1213.
4. Brophy CM, Reilly JM, Smith GJ, Tilson MD. The role of inflammation in nonspecific abdominal aortic aneurysm disease. Ann Vasc Surg 1991; 5:229-233.
5. Patel MI, Hardman DT, Fisher CM, Appleberg M. Current views on the pathogenesis of abdominal aortic aneurysms. J Am Coll Surg 1995; 181:371-382.
6. Elefteriades JA. Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. Ann Thorac Surg 2002; 74:S1877-S1880; discussion S1892.
7. Herron GS, Unemori E, Wong M, Rapp JH, Hibbs MH, Stoney RJ. Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. Arterioscler Thromb 1991; 11:1667-1677.
8. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1995; 15:1145-1151.
9. Shah PK. Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation 1997; 96:2115-2117.
10. Knox JB, Sukhova GK, Whittemore AD, Libby P. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 1997; 95:205-212.
11. Karakaya O, Barutcu I, Esen AM, Dogan S, Saglam M, Karapinar H, Akgun T, Karavelioglu Y, Esen O, Ozdemir N, Turkmen S, Kaymaz C. Relationship between circulating plasma matrix metalloproteinase-9 (gelatinase-B) concentration and aortic root dilatation. Am J Hypertens 2006; 19:361-365.
12. Dubick MA, Keen CL, DiSilvestro RA, Eskelson CD, Ireton J, Hunter GC. Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease. Proc Soc Exp Biol Med 1999; 220:39-45.
13. Zhang J, Schmidt J, Ryschich E, Mueller-Schilling M, Schumacher H, Allenberg JR. Inducible nitric oxide synthase is present in human abdominal aortic aneurysm and promotes oxidative vascular injury. J Vasc Surg 2003; 38:360-367.
14. Grote K, Flach I, Luchtefeld M, Akin E, Holland SM, Drexler H, Schieffer B. Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res 2003; 92:e80-e86.
15. Brenneisen P, Briviba K, Wlaschek M, Wenk J, Scharffetter-Kochanek K. Hydrogen peroxide (H2O2) increases the steady-state mRNA levels of collagenase/MMP-1 in human dermal fibroblasts. Free Radic Biol Med 1997; 22:515-524.
16. McCormick ML, Gavrila D, Weintraub NL. Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2007; 27:461-469.
17. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharm Des 2005; 11:4145-4151.
18. Kaur H, Halliwell B. Action of biologically-relevant oxidizing species upon uric acid. Identification of uric acid oxidation products. Chem Biol Interact 1990; 73:235-247.
19. Hellsten Y, Svensson M, Sjödin B, Smith S, Christensen A, Richter EA, Bangsbo J. Allantoin formation and urate and glutathione exchange in human muscle during submaximal exercise. Free Radic Biol Med 2001; 31:1313-1322.
20. Yeum KJ, Russell RM, Krinsky NI, Aldini G. Biomarkers of antioxidant capacity in the hydrophilic and lipophilic compartments of human plasma. Arch Biochem Biophys 2004; 430:97-103.
21. Stefanadis C, Wooley CF, Bush CA, Kolibash AJ, Geleris P, Boudoulas H. Segmental analysis of the ascending aorta: definition of normality and classification of aortic dilatation. J Cardiol 1989; 19:945-953.
22. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463.
23. George J, Struthers AD. Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress. Vasc Health Risk Manag 2009; 5:265-272.
24. Parks DA, Williams TK, Beckman JS. Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation. Am J Physiol 1988; 254: G768-G774.
25. Patetsios P, Rodino W, Wisselink W, Bryan D, John D, Krwin JD, Panetta TF. The abdominal aortic aneurysm: Genetics, pathophysiology, and molecular biology. Ann NY Acad Sci 2006;1085:1-408.
26. Dalman RL. Oxidative stress and abdominal aneurysms: how aortic hemodynamic conditions may influence AAA disease. Cardiovasc Surg 2003; 11:417-419.
27. Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol (Lond) 2004; 555:589-606.
28. Tsukimori K, Yoshitomi T, Morokuma S, Fukushima K, Wake N. Serum uric acid levels correlate with plasma hydrogen peroxide and protein carbonyl levels in preeclampsia. Am J Hypertens 2008; 21:1343-1346.
29. Jia SD, Wang YG, Li HF, Li J, Wang HY. [Oxidative stress and endothelial dysfunction at different serum uric acid levels]. Zhonghua Nei Ke Za Zhi 2008; 47:638-641.
30. Maxwell SR, Thomason H, Sandler D, Leguen C, Baxter MA, Thorpe GH, Jones AF, Barnett AH. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1997; 27:484-490.
31. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999; 131:7-13.
32. Hsu SP, Pai MF, Peng YS, Chiang CK, Ho TI, Hung KY. Serum uric acid levels show a 'J-shaped' association with all-cause mortality in haemodialysis patients. Nephrol Dial Transplant 2004; 19:457-462.
33. Palmieri V, Bella JN, Arnett DK, Roman MJ, Oberman A, Kitzman DW, Hopkins PN, Paranicas M, Rao DC, Devereux RB. Aortic root dilatation at sinuses of valsalva and aortic regurgitation in hypertensive and normotensive subjects: The Hypertension Genetic Epidemiology Network Study. Hypertension 2001; 37:1229-1235.
34. Cuspidi C, Meani S, Fusi V, Valerio C, Sala C, Zanchetti A. Prevalence and correlates of aortic root dilatation in patients with essential hypertension: relationship with cardiac and extracardiac target organ damage. J Hypertens 2006; 24:573-580.
35. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 2004; 44:248-252.
36. Lassègue B, Griendling KK. Reactive oxygen species in hypertension; An update. Am J Hypertens 2004; 17:852-860.